| Primary |
| Product Used For Unknown Indication |
91.3% |
| Grand Mal Convulsion |
4.3% |
| Schizophrenia |
4.3% |
|
| Poisoning |
44.4% |
| Completed Suicide |
11.1% |
| Incorrect Dose Administered |
11.1% |
| Mental Status Changes |
11.1% |
| Status Epilepticus |
11.1% |
| Suicide Attempt |
11.1% |
|
| Secondary |
| Product Used For Unknown Indication |
64.5% |
| Status Epilepticus |
6.1% |
| Insomnia |
3.7% |
| Seizures |
3.7% |
| Drug Use For Unknown Indication |
3.3% |
| Suicide Attempt |
3.3% |
| Attempted Suicide |
2.3% |
| Epilepsy |
2.3% |
| Drug Abuse |
1.9% |
| Drug Use For Unknown Indication |
1.4% |
| Nausea |
0.9% |
| Catatonia |
0.9% |
| Completed Suicide |
0.9% |
| Intentional Self-injury |
0.9% |
| Major Depression |
0.9% |
| Sleep Disorder |
0.9% |
| Catatonic Schizophrenia |
0.5% |
| Abnormal Dreams |
0.5% |
| Anxiety |
0.5% |
| Asthma |
0.5% |
|
| Toxicity To Various Agents |
34.6% |
| Unresponsive To Stimuli |
7.7% |
| Completed Suicide |
5.8% |
| Respiratory Arrest |
5.8% |
| Somnolence |
5.8% |
| Drug Abuse |
3.8% |
| No Therapeutic Response |
3.8% |
| Psychomotor Hyperactivity |
3.8% |
| Sopor |
3.8% |
| Suicide Attempt |
3.8% |
| Syncope |
3.8% |
| Blood Pressure Increased |
1.9% |
| Drug Resistance |
1.9% |
| Hypothermia |
1.9% |
| Hypovolaemia |
1.9% |
| Incorrect Dose Administered |
1.9% |
| Increased Tendency To Bruise |
1.9% |
| Intentional Drug Misuse |
1.9% |
| Major Depression |
1.9% |
| Muscle Contractions Involuntary |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.6% |
| Plasma Cell Myeloma |
21.6% |
| Multiple Sclerosis |
8.0% |
| Depression |
7.5% |
| Drug Use For Unknown Indication |
5.5% |
| Osteoporosis |
4.0% |
| Breast Cancer |
3.5% |
| Hypertension |
3.0% |
| Prostate Cancer Metastatic |
3.0% |
| Acute Myeloid Leukaemia |
2.5% |
| Agitation |
2.0% |
| Chronic Myeloid Leukaemia |
2.0% |
| Colorectal Cancer Metastatic |
2.0% |
| Glioblastoma |
2.0% |
| Osteoarthritis |
2.0% |
| Ovarian Cancer |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Bone Marrow Conditioning Regimen |
1.5% |
| Constipation |
1.5% |
| Convulsion |
1.5% |
|
| Vomiting |
11.0% |
| Rash |
9.8% |
| Thrombocytopenia |
6.1% |
| Death |
4.9% |
| Fatigue |
4.9% |
| Pancytopenia |
4.9% |
| Rectal Haemorrhage |
4.9% |
| Somnolence |
4.9% |
| Toxicity To Various Agents |
4.9% |
| Tremor |
4.9% |
| Unresponsive To Stimuli |
4.9% |
| Urticaria |
4.9% |
| Dyspnoea |
3.7% |
| Full Blood Count Decreased |
3.7% |
| Myocardial Infarction |
3.7% |
| Nausea |
3.7% |
| Pain In Extremity |
3.7% |
| Pyrexia |
3.7% |
| Thinking Abnormal |
3.7% |
| Urinary Tract Infection |
3.7% |
|
